Press "Enter" to skip to content

Tag: research

Fall COVID-19 vaccine cut illness risk by half overall

The fall COVID-19 vaccine cut the risk of COVID-19 illness by about half overall, and by 67 per cent for those with a previous infection, according to new research from the Canadian network that has long tracked the performance of the annual flu shot.

This is the first time the Canadian Sentinel Practitioner Surveillance Network, which is comprised of hundreds of primary care providers in British Columbia, Alberta, Ontario and Quebec, produced mid-season estimates of the effectiveness of immunization against COVID-19.

Comments closed

Irish scientists discover why people with long Covid can suffer ‘brain fog’

The reason why people with long Covid can suffer from “brain fog” has been discovered by Irish scientists.

The breakthrough has profound importance for the understanding of brain fog and cognitive decline seen in some patients with the condition, according researchers at Trinity College Dublin.

It brings the possibility of new treatments for the condition, but also for other neurodegenerative illnesses such as multiple sclerosis (MS), they said.

The research, published in Nature Neuroscience on Thursday, shows disruption to the integrity of blood vessels in the brains of patients suffering from long Covid and brain fog.

Comments closed

Long Covid ‘brain fog’ may be due to leaky blood-brain barrier, study finds

From forgetfulness to difficulties concentrating, many people who have long Covid experience “brain fog”. Now researchers say the symptom could be down to the blood-brain barrier becoming leaky.

The barrier controls which substances or materials enter and exit the brain. “It’s all about regulating a balance of material in blood compared to brain,” said Prof Matthew Campbell, co-author of the research at Trinity College Dublin.

“If that is off balance then it can drive changes in neural function and if this happens in brain regions that allow for memory consolidation/storage then it can wreak havoc.”

Writing in the journal Nature Neuroscience, Campbell and colleagues report how they analysed serum and plasma samples from 76 patients who were hospitalised with Covid in March or April 2020, as well 25 people before the pandemic.

Comments closed

Paxlovid use tied to 84% lower risk of hospital care

University of North Carolina–Chapel Hill investigators report today that COVID-19 hospitalization risk was reduced by 84% among Paxlovid (nirmatrelvir and ritonavir) recipients in a large, diverse healthcare system during January to August 2022, when the Omicron strain was dominant.

The study appears in the Journal of Antimicrobial Chemotherapy. Paxlovid is authorized for use in US patients 12 years and older at risk for developing severe outcomes from COVID-19 infections. In early clinical trials, the use of the antiviral drug was associated with a relative risk reduction of 89% of disease progression to severe illness.

Comments closed

Study shows 43% to 58% lower prevalence of long COVID among vaccinated people

A new study based on 4,605 participants in the Michigan COVID-19 Recovery Surveillance Study shows that the prevalence of long COVID symptoms at 30 and 90 days post-infection was 43% to 58% lower among adults who were fully vaccinated before infection.

The study appeared yesterday in the Annals of Epidemiology.

The 30- and 90-day timeframes were meant to compare two different definitions of long COVID. The US Centers for Disease Control and Prevention defines the condition as new or persistent symptoms 4 weeks after infection, while the World Health Organization definition defines it as 12 or more weeks after infection.

Comments closed

Canadian data show moderate to good vaccine efficacy against COVID, flu

The Canadian Sentinel Practitioner Surveillance Network (SPSN) data reveal mid-season vaccine effectiveness (VE) against the SARS-CoV-2 Omicron XBB.1.5 variant of 47% against medically attended outpatient COVID-19 and 67% among previously infected people.

The same test-negative case-control study reports that the flu vaccine is 63% effective against medically attended outpatient infection with the influenza A H1N1 strain and 40% against H3N2.

The researchers enrolled patients with new or worsening cough that is characteristic of acute respiratory illness (ARI) who sought care within 7 days of symptom onset from community-based sentinel practitioners in Alberta, British Columbia (BC), Ontario, or Quebec.

Comments closed

Researchers report COVID home tests as accurate as the same tests given by a clinician

A single-center study conducted at a free community testing site in Maryland suggests that patient-administered BinaxNow COVID-19 rapid antigen tests (RATs) have similar accuracy as those performed by a clinician, although the results can be misinterpreted or falsely negative.

Researchers from the Baltimore Convention Center Field Hospital and Johns Hopkins University and their collaborators compared the sensitivity and specificity of Abbott’s BinaxNOW home RAT with those administered by a healthcare provider and reverse transcription-polymerase chain reaction (RT-PCR) from February to July 2022, a period of Omicron variant predominance.

The median age of the 953 participants was 34 years, 60.6% were women, 58.6% were White, 98.2% were English-speaking, and 34.1% had at least one COVID-19 symptom. Hospital staff administered both a RAT and an RT-PCR test to participants, who then self-tested with a RAT, the results of which were both self-reported and reviewed by the researchers.

Comments closed

COVID patients are 4.3 times more likely to develop chronic fatigue, CDC report finds

COVID-19 patients are at least four times more likely to develop chronic fatigue than someone who has not had the virus, a new federal study published Wednesday suggests.

Researchers from the Centers for Disease Control and Prevention (CDC) looked at electronic health records from the University of Washington of more than 4,500 patients with confirmed COVID-19 between February 2020 and February 2021.

They were followed for a median of 11.4 months and their health data was compared with the data of more than 9,000 non-COVID-19 patients with similar characteristics.

Fatigue developed in 9% of the COVID patients, the team found. Among COVID-19 patients, the rate of new cases of fatigue was 10.2 per 100 person-years and the rate of new cases of chronic fatigue was 1.8 per 100 person-years.

Comments closed

Covid-19: Vaccines saved thousands of lives during Omicron outbreak, study estimates

A new study estimates vaccines prevented between 4000 and 12,000 deaths during the Omicron phase of the Covid-19 pandemic.

The paper, published in the medical journal Vaccine, models scenarios with different levels of vaccine coverage in the 18 months from January 2022.

The authors say the elimination strategy meant most people were able to be vaccinated before being exposed to the virus.

The researchers say it meant there were between 34,000 and 56,000 fewer hospitalisations over the period.

Comments closed

New Analysis Reveals Many Excess Deaths Attributed to Natural Causes Are Actually Uncounted COVID-19 Deaths

Nearly 1,170,000 people have died from COVID-19 in the United States according to official federal counts, but multiple excess mortality studies suggest that these totals are vastly undercounted. While excess mortality provides an estimation of deaths that likely would not have occurred under normal, non-pandemic conditions, there is still little evidence into whether the SARS-CoV-2 virus contributed to these additional deaths, or whether these deaths were caused by other factors such as healthcare disruptions or socioeconomic challenges.

Now, a new study led by the School of Public Health and the University of Pennsylvania (UPenn) provides the first concrete data showing that many of these excess deaths were indeed uncounted COVID-19 deaths.

Comments closed

Air sampling in Dane County schools tracks flu, COVID-19

Air sampling in Dane County schools is helping health officials track flu and COVID-19, similar to how wastewater is increasingly monitored around the country for the coronavirus to gauge activity as fewer people get tested for COVID-19.

Since the beginning of the school year, flu and COVID-19 data from 16 air monitors at 15 schools in or near the county has been reported on Public Health Madison and Dane County’s respiratory illness dashboard. The devices, roughly the size of microwave ovens, are placed in communal spaces such as cafeterias. They suck air, including airborne viruses, into spongy material that is analyzed for viral genetic material.

Comments closed

Homeless people in Toronto more likely to get COVID again compared to housed population: study

People who are homeless have high rates of COVID-19 reinfection, putting the health of an already vulnerable population at further risk, a study published Friday in the BMC Infectious Diseases journal says.

Homeless people in Toronto who had COVID-19 were more than twice as likely to get it again as people who had housing, said lead author Lucie Richard, a senior research associate at the MAP Centre for Urban Health Solutions at St. Michael’s Hospital.

Comments closed

New estimates show latest COVID vaccine cuts risk of symptomatic infection

Today in Morbidity and Mortality Weekly Report, researchers published findings showing adults who received an updated 2023-24 COVID-19 vaccine were 54% less likely to have symptomatic infection than those who didn’t, and the vaccine was found to protect against JN.1 and other circulating variants.

This is one of the first studies to update 2023-24 COVID vaccine effectiveness (VE) data. The monovalent (single-strain) booster vaccine derived from XBB.1.5 was approved for use in all Americans 6 months and older on September 12, 2023, but uptake has been low. Moreover, the XBB strains of the virus, which the vaccine was based on, are no longer the dominant strains in the United States, having been replaced by JN.1 in December 2023.

Comments closed

Study: Cognitive slowing is associated with long COVID

In an attempt to establish a definitive objective cognitive marker for PCC, or post-COVID-19 condition, researchers tested long COVID patients in Germany and the United Kingdom with cognitive speed tests, and found long COVID patients have a significant lag, suggesting cognitive slowing.

The study, published yesterday in eClincialMedicine, was based on findings on an initial 194 long COVID patient seen at a PCC clinic in Germany. Findings were then replicated in a follow up COVID clinic in the United Kingdom.

All study participants had one or more symptoms of PCC at least 12 weeks following a lab-confirmed COVID-19 infection. They were compared to two control groups, one group that had never had a COVID-19 infection and one group that had COVID-19 12 or more weeks prior but no evidence of PCC.

Comments closed

New long COVID study uncovers high inflammation in patients as Senate calls for more research on ‘crisis’

The burden of disease and disability from long COVID is on par with the burden of cancer and heart disease. We must develop sustainable solutions to prevent repeated infections with SARS-CoV-2 and long COVID that would be embraced by the public.

—Dr. Ziyad Al-Aly
Comments closed

Montreal university study describes COVID-19 sanitary measures as ‘generally effective’

A study aimed at countering online misinformation finds that health measures taken by governments to protect against COVID-19 helped save lives and reduce the number of people hospitalized in 2020.

Comments closed